Laboratorios Nacionales de Biológicos y Reactrivos Report issue

Government Phase 4

Organization Overview

First Clinical Trial
2010
NCT01875952
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Alternative names

Laboratorios Nacionales de Biológicos y Reactrivos (BIRMEX)

Active Ingredients

Drugs in Phase 4 Trials (1)

isoniazid (nydrazid) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acquired Immunodeficiency Syndrome (Phase 4)

Coinfection (Phase 4)

Communicable Diseases (Phase 4)

HIV Infections (Phase 4)

Immunologic Deficiency Syndromes (Phase 4)

Infections (Phase 4)

Latent Tuberculosis (Phase 4)

Tuberculosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1